Bank of New York Mellon
GOSS icon

Bank of New York Mellon’s Gossamer Bio GOSS Stock Holding History

Bank of New York Mellon’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.52K Sell
45,713
-382,528
-89% -$107K ﹤0.01% 4285
2026
Q1 		$141K Sell
428,241
-19,660
-4% -$30.9K ﹤0.01% 4068
2025
Q4 		$1.39M Sell
447,901
-310
-0.1% -$885 ﹤0.01% 3057
2025
Q3 		$1.18M Buy
448,211
+61,503
+16% +$136K ﹤0.01% 3116
2025
Q2 		$476K Buy
386,708
+366,489
+1,813% +$400K ﹤0.01% 3535
2025
Q1 		$22.2K Sell
20,219
-1
-0% -$1 ﹤0.01% 4085
2024
Q4 		$18.3K Hold
20,220
– – ﹤0.01% 4104
2024
Q3 		$19.9K Buy
20,220
+2
+0% +$2 ﹤0.01% 4071
2024
Q2 		$18.2K Hold
20,218
– – ﹤0.01% 4084
2024
Q1 		$23.9K Sell
20,218
-71,028
-78% -$78.2K ﹤0.01% 4109
2023
Q4 		$83.3K Hold
91,246
– – ﹤0.01% 4114
2023
Q3 		$76K Buy
91,246
+58,428
+178% +$67.3K ﹤0.01% 4120
2023
Q2 		$39.4K Sell
32,818
-184,236
-85% -$229K ﹤0.01% 4210
2023
Q1 		$273K Sell
217,054
-3,782
-2% -$7.24K ﹤0.01% 3784
2022
Q4 		$479K Sell
220,836
-46,504
-17% -$383K ﹤0.01% 3557
2022
Q3 		$3.2M Buy
267,340
+74,450
+39% +$924K ﹤0.01% 2544
2022
Q2 		$1.61M Sell
192,890
-35,133
-15% -$272K ﹤0.01% 2951
2022
Q1 		$1.98M Sell
228,023
-173
-0.1% -$1.67K ﹤0.01% 2949
2021
Q4 		$2.58M Sell
228,196
-6
-0% -$71 ﹤0.01% 2837
2021
Q3 		$2.87M Buy
228,202
+17,664
+8% +$163K ﹤0.01% 2785
2021
Q2 		$1.71M Sell
210,538
-23,737
-10% -$206K ﹤0.01% 3100
2021
Q1 		$2.17M Sell
234,275
-2,558
-1% -$25.8K ﹤0.01% 2882
2020
Q4 		$2.29M Buy
236,833
+10,650
+5% +$105K ﹤0.01% 2767
2020
Q3 		$2.81M Buy
226,183
+4,891
+2% +$64.8K ﹤0.01% 2488
2020
Q2 		$2.88M Buy
221,292
+45,911
+26% +$577K ﹤0.01% 2477
2020
Q1 		$1.78M Sell
175,381
-2,964
-2% -$38.7K ﹤0.01% 2614
2019
Q4 		$2.79M Buy
178,345
+16,267
+10% +$328K ﹤0.01% 2626
2019
Q3 		$2.72M Buy
162,078
+56,786
+54% +$1.13M ﹤0.01% 2579
2019
Q2 		$2.33M Buy
105,292
+54,478
+107% +$1.04M ﹤0.01% 2724
2019
Q1 		$1.1M Buy
+50,814
New +$1.06M ﹤0.01% 3105

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MGW
MB Generational Wealth Spokane, Washington $204M AUM 25.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of New York Mellon's GOSS Position: Q2 2026 in Review

Bank of New York Mellon reduced its Gossamer Bio (GOSS) stake by 89% in Q2 2026, selling an estimated $107K and leaving 45,713 shares worth $7.52K. The position accounts for ﹤0.01% of the portfolio, ranked #4285.

Bank of New York Mellon first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.2M in Q3 2022. 66 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Bank of New York Mellon held 45,713 shares of Gossamer Bio worth $7.52K as of Q2 2026.
  • Bank of New York Mellon sold 382,528 Gossamer Bio shares in Q2 2026, an estimated $107K.
  • Gossamer Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4285 holding.
  • Bank of New York Mellon first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Bank of New York Mellon's Gossamer Bio position peaked at $3.2M in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.